MedPath

AUSTRALIAN NATIONAL UNIVERSITY

🇦🇺Australia
Ownership
-
Established
1946-01-01
Employees
-
Market Cap
-
Website
https://www.anu.edu.au/

Clinical Trials

37

Active:3
Completed:14

Trial Phases

4 Phases

Phase 1:1
Phase 2:5
Phase 4:2
+1 more phases

Drug Approvals

0

Drug Approvals

No drug approvals found

This company may not have drug approvals in our database

Clinical Trials

Distribution across different clinical trial phases (34 trials with phase data)• Click on a phase to view related trials

Not Applicable
26 (76.5%)
Phase 2
5 (14.7%)
Phase 4
2 (5.9%)
Phase 1
1 (2.9%)

Inhaled Heparin for Hospitalised Patients With Coronavirus Disease 2019 (COVID-19)

Phase 2
Withdrawn
Conditions
COVID-19
Interventions
First Posted Date
2022-01-11
Last Posted Date
2024-02-26
Lead Sponsor
Australian National University
Registration Number
NCT05184101
Locations
🇦🇺

St George Hospital, Kogarah, New South Wales, Australia

Inhaled Heparin for Hospitalised COVID-19 Patients

Phase 2
Completed
Conditions
Covid19
Interventions
First Posted Date
2020-11-19
Last Posted Date
2025-06-17
Lead Sponsor
Australian National University
Target Recruit Count
485
Registration Number
NCT04635241
Locations
🇦🇷

San Camilo Clinic, Buenos Aires, Argentina

🇪🇬

15th May hospital, Cairo, Egypt

🇮🇩

RS Universitas Indonesia, Depok, Indonesia

and more 2 locations

Nebulised Heparin in Patients With Severe COVID-19

Phase 2
Active, not recruiting
Conditions
Covid19
Respiratory Failure
Interventions
Drug: Nebulised unfractionated heparin (UFH)
First Posted Date
2020-09-11
Last Posted Date
2025-02-03
Lead Sponsor
Australian National University
Target Recruit Count
57
Registration Number
NCT04545541
Locations
🇺🇸

Frederick Health Hospital, Frederick, Maryland, United States

Family Violence and Alcohol and Drug Misuse in Sri Lanka

Not Applicable
Completed
Conditions
Intimate Partner Violence
Domestic Abuse
Drug and Alcohol Abuse
First Posted Date
2017-11-14
Last Posted Date
2019-07-05
Lead Sponsor
Australian National University
Target Recruit Count
900
Registration Number
NCT03341455
Locations
🇦🇺

Australian National University, Canberra, Australian Capital Territory, Australia

IN2SHAPE: A Study of Physical Activity and Depressive Symptoms in Adolescence

Not Applicable
Completed
Conditions
Depression
First Posted Date
2008-08-20
Last Posted Date
2012-07-20
Lead Sponsor
Australian National University
Target Recruit Count
26
Registration Number
NCT00738634
Locations
🇦🇺

The Centre for Mental Health Research, Canberra, Australian Capital Territory, Australia

  • Prev
  • 1
  • 2
  • Next

News

Medibank Partners with Emyria to Fund Innovative PTSD Treatment Program in Australian Healthcare First

Medibank, Australia's largest private health insurer, has entered a multi-year partnership with Emyria to fund the Empax PTSD care program, marking the first time a major private health insurer has funded an ethics-approved, psychiatrist-led trauma therapy program.

© Copyright 2025. All Rights Reserved by MedPath